Cameco Trades Near $85. Here's Why the Uranium Giant Might Be the Safest Way to Play the Nuclear Comeback

Cameco is presented as a long-term beneficiary of a nuclear-power revival, with U.S. electricity demand projected to grow 60% from 2025 to 2045 versus 10% over 2005-2025. The company expects uranium demand to exceed supply in the early 2030s, potentially supporting uranium prices and its mining and nuclear-fuel operations. Cameco also owns 50% of Westinghouse, adding relatively steadier nuclear-services cash flows; its shares have retraced to roughly $85 after ranging from about $85 to $134 over the past year.

Analysis

CCJ/CCO is better viewed as a contracted-nuclear infrastructure compounder than a pure uranium-beta vehicle. The key rerating mechanism is not a near-term spot-price spike, but evidence that utilities are accelerating long-duration contracting at higher floor prices; that would improve earnings visibility and justify a premium multiple versus smaller miners. Westinghouse also creates a differentiated route to monetize life extensions, fuel reloads and reactor-service spending, reducing the commodity cyclicality embedded in most uranium equities.

The near-term setup is less compelling than the long-duration thesis: retail nuclear enthusiasm has historically produced sharp multiple expansion before procurement activity reaches reported financials. Over the next 1-3 months, watch disclosed contracting volumes, realized uranium pricing, production reliability at Canadian operations, and Westinghouse EBITDA/cash-distribution commentary. A failure to replace depleted contract coverage, or another production shortfall that forces open-market purchases, would undermine the thesis even if uranium spot prices remain firm.

The useful relative-value expression is long CCJ against pre-revenue reactor developers OKLO and SMR. Their valuations require favorable licensing, construction, financing and customer-conversion outcomes simultaneously, whereas CCJ benefits from incremental nuclear fleet spending regardless of which reactor design wins. Contrarian risk: if policy support shifts toward gas generation to meet data-center demand faster, reactor build schedules may slip without materially reducing near-term uranium supply, leaving the sector exposed to a multi-quarter de-rating.

Key Decisions for Investors

• Accumulate CCJ/CCO in tranches near the recent $85 area rather than chase nuclear-theme momentum; use a 12-18 month horizon, with a $72 break or a material cut to production/contracting guidance as the thesis stop.
• Express relative value over 3-6 months: long CCJ and short a basket of OKLO/SMR, sized beta-neutral. The pair should work if capital markets reprice execution risk at reactor developers while utility fuel and service procurement remains intact; cover the short leg on a major binding customer contract, definitive project financing, or licensing milestone.
• Do not buy CCJ calls until implied volatility and term structure are checked; the missing inputs are option IV, open interest and downside skew. If volatility is elevated after a thematic rally, stock or call spreads are preferable to outright calls.
• Set an earnings alert around three verifiable indicators: higher long-term contract volumes, stable/lower unit production costs, and improving Westinghouse cash contribution. Two of three missing would argue for reducing exposure, as the valuation case then reverts to spot-uranium sensitivity.